SINGAPORE (Oct 30): Tianjin Zhong Xin Pharmaceutical Group Corporation posts an 11% decline in earnings to RMB 82.0 million ($16.8 million) for the 3Q ended September, from RMB 91.6 million a year ago.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply